wholesale

111 Inc reports first ever opertaing profit

Inaugural operating profit fails to lift 111 Inc.

The drug distributor expects to benefit from an ongoing crackdown on corruption in its industry due to the company’s focus on distribution to pharmacies rather than hospitals Key Takeaways: 111…
YI.US

Recent Articles

RELATED ARTICLES

  1. Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs.
    Akeso marks profit milestone with swift rights issue
    9926.HK
  2. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  3. Hutchmed scores U.S. success with cancer drug, but profits still dip
    HCM.US 0013.HK
  4. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
  5. Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs
  6. BeiGene still bleeding red ink despite blockbuster drug
    BGNE.US 6160.HK 688235.SHG
  7. Profit setback for Simcere Pharma in novel drugs quest
    2096.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva